A
Antabio
Biotech & Life Sciences · Labège, France · Founded 2009
Antabio is a clinical-stage biopharmaceutical company developing novel antibacterials targeting drug-resistant pathogens that are deemed a critical priority by the WHO MoreLess
Operator of a private European biopharmaceutical company intended to develop novel and highly differentiated antibacterial treatments. The company's resistance-breakers develop stand-alone inhibitors of bacterial metalloenzymes that can be combined with various antibiotics to restore their activity against the most critical pathogens, enabling health professionals to get access to medicinal products that help in curing drug-resistant diseases. Keywords: Pharmaceuticals and Biotechnology, Antiinfective Product, Antimicrobial Resistance, Antimicrobial Resistance Treatment, Carbapenem-Resistant, Chronic Pulmonary, Drug Development, Nosocomial Infectious Disease, Nosocomial Pneumonia, Pseudomonas Aeruginosa.
Company overview
Antabio company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2009
- Headquarters
- Labège, France
- Employees
- 25
- Open positions
- 1
- Dealroom signal
- 81.2
- Investment activity
- 1 companies · latest Jan 2022
- Capital deployed
- $9M
- Preferred round
- EARLY VC
Valuation & funding
Antabio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Dec 2023 | $28M | $110M | Irdi Capital Investissement · Turenne Capital · BNP Paribas Développement · AMR Action Fund | ↗ |
| CONVERTIBLEOther financing | Jun 2023 | $3.3M | — | EIC Fund | — |
| EARLY VCOther financing | Jun 2022 | $0 | — | EIC Fund | — |
| GRANTOther financing | Jun 2022 | $2.5M | — | European Innovation Council | — |
| SERIES AOther financing | Oct 2018 | $9.2M | $37M | iXO Private Equity · BNP Paribas Développement · Irdi Capital Investissement · Turenne Capital | ↗ |
| GRANTOther financing | Jul 2017 | CARB-X | ↗ | ||
| GRANTOther financing | May 2015 | Wellcome Trust | — | ||
| GRANTOther financing | Feb 2013 | Wellcome Trust | — | ||
| SEEDOther financing | Jan 2010 | Business Angel Pool | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $33K | 0% | 25 |
| 2025 | $33K | 0% | 24 |
| 2024 | $33K | 0% | 20 |
| 2023 | $33K | 0% | 16 |
| 2022 | $33K | 0% | — |
| 2021 | $33K | 0% | — |
| 2020 | $33K | — | — |
Growth signals
Antabio website traffic
Latest recorded traffic for Antabio is 1.7K monthly website visits, up 41.7% over the last three months. Antabio's team grew 4.2% over the past year.
Hiring
Open positions at Antabio
Current openings linked to this company in Dealroom.
Comparisons
Antabio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Antabio investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
Antabio's talent
Source: Dealroom Talent Intelligence.
Investors
12 investors on Antabio's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Antabio has talent and traffic
team presence
In the news
Latest news about Antabio
Recent press, funding announcements, and product moves mentioning Antabio — open to read from the original sources.
Market sentiment
What the market is saying about Antabio
An AI-synthesized read of the highest-engagement posts about Antabio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Antabio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.